These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22747749)

  • 21. MTHFR gene polymorphisms in bladder cancer in the Turkish population.
    Izmirli M; Inandiklioglu N; Abat D; Alptekin D; Demirhan O; Tansug Z; Bayazit Y
    Asian Pac J Cancer Prev; 2011; 12(7):1833-5. PubMed ID: 22126575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individual variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms.
    Agusa T; Fujihara J; Takeshita H; Iwata H
    Int J Mol Sci; 2011; 12(4):2351-82. PubMed ID: 21731446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms.
    Lindberg AL; Kumar R; Goessler W; Thirumaran R; Gurzau E; Koppova K; Rudnai P; Leonardi G; Fletcher T; Vahter M
    Environ Health Perspect; 2007 Jul; 115(7):1081-6. PubMed ID: 17637926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-level arsenic exposure, AS3MT gene polymorphism and cardiovascular diseases in rural Texas counties.
    Gong G; O'Bryant SE
    Environ Res; 2012 Feb; 113():52-7. PubMed ID: 22341486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire.
    Lesseur C; Gilbert-Diamond D; Andrew AS; Ekstrom RM; Li Z; Kelsey KT; Marsit CJ; Karagas MR
    Toxicol Lett; 2012 Apr; 210(1):100-6. PubMed ID: 22306368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA.
    Meliker JR; Slotnick MJ; AvRuskin GA; Schottenfeld D; Jacquez GM; Wilson ML; Goovaerts P; Franzblau A; Nriagu JO
    Cancer Causes Control; 2010 May; 21(5):745-57. PubMed ID: 20084543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between 5,10-methylenetetrahydrofolate reductase genetic polymorphism and arsenic metabolism].
    Deng FR; Guo XB; Chen L; Wang ZQ; Zhang K
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 39(2):149-52. PubMed ID: 17440589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer.
    Karagas MR; Andrew AS; Nelson HH; Li Z; Punshon T; Schned A; Marsit CJ; Morris JS; Moore JH; Tyler AL; Gilbert-Diamond D; Guerinot ML; Kelsey KT
    Hum Genet; 2012 Mar; 131(3):453-61. PubMed ID: 21947419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of polymorphism of arsenic metabolism genes to arsenic methylation capacity and developmental delay in preschool children in Taiwan.
    Hsieh RL; Su CT; Shiue HS; Chen WJ; Huang SR; Lin YC; Lin MI; Mu SC; Chen RJ; Hsueh YM
    Toxicol Appl Pharmacol; 2017 Apr; 321():37-47. PubMed ID: 28235556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bladder cancer and arsenic through drinking water: a systematic review of epidemiologic evidence.
    Christoforidou EP; Riza E; Kales SN; Hadjistavrou K; Stoltidi M; Kastania AN; Linos A
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2013; 48(14):1764-75. PubMed ID: 24007431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does occupational exposure to solvents and pesticides in association with glutathione S-transferase A1, M1, P1, and T1 polymorphisms increase the risk of bladder cancer? The Belgrade case-control study.
    Matic MG; Coric VM; Savic-Radojevic AR; Bulat PV; Pljesa-Ercegovac MS; Dragicevic DP; Djukic TI; Simic TP; Pekmezovic TD
    PLoS One; 2014; 9(6):e99448. PubMed ID: 24914957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms in AS3MT and arsenic metabolism in residents of the Red River Delta, Vietnam.
    Agusa T; Iwata H; Fujihara J; Kunito T; Takeshita H; Minh TB; Trang PT; Viet PH; Tanabe S
    Toxicol Appl Pharmacol; 2009 Apr; 236(2):131-41. PubMed ID: 19371612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms in DNA repair and metabolic genes in bladder cancer.
    Sanyal S; Festa F; Sakano S; Zhang Z; Steineck G; Norming U; Wijkström H; Larsson P; Kumar R; Hemminki K
    Carcinogenesis; 2004 May; 25(5):729-34. PubMed ID: 14688016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in arsenic(+III oxidation state) methyltransferase (AS3MT) predict gene expression of AS3MT as well as arsenic metabolism.
    Engström K; Vahter M; Mlakar SJ; Concha G; Nermell B; Raqib R; Cardozo A; Broberg K
    Environ Health Perspect; 2011 Feb; 119(2):182-8. PubMed ID: 21247820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Micronucleus frequency in copper-mine workers exposed to arsenic is modulated by the AS3MT Met287Thr polymorphism.
    Hernández A; Paiva L; Creus A; Quinteros D; Marcos R
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Jan; 759():51-5. PubMed ID: 24361376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men.
    Safarinejad MR; Shafiei N; Safarinejad S
    Med Oncol; 2011 Dec; 28 Suppl 1():S398-412. PubMed ID: 21046286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MTHFR gene polymorphisms and bladder cancer susceptibility: a meta-analysis including race, smoking status and tumour stage.
    Kouidhi S; Rouissi K; Khedhiri S; Ouerhani S; Cherif M; Benammar-Elgaaied A
    Asian Pac J Cancer Prev; 2011; 12(9):2227-32. PubMed ID: 22296361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between the polymorphism of three genes involved in the methylation and efflux of arsenic (As3MT, MRP1, and P-gp) with lung cancer in a Mexican cohort.
    Recio-Vega R; Hernandez-Gonzalez S; Michel-Ramirez G; Olivas-Calderón E; Lantz RC; Gandolfi AJ; Amistadi MK
    J Appl Toxicol; 2021 Sep; 41(9):1357-1366. PubMed ID: 33340130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between PNP, GSTO-1, AS3MT and ADRB3 gene polymorphisms and urinary arsenic concentration among copper smelter and refinery employers.
    Szymańska-Chabowska A; Matys T; Łaczmański Ł; Czerwińska K; Janus A; Smyk B; Mazur G; Poręba R; Gać P
    Hum Exp Toxicol; 2020 Nov; 39(11):1443-1453. PubMed ID: 32452228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina.
    Schläwicke Engström K; Broberg K; Concha G; Nermell B; Warholm M; Vahter M
    Environ Health Perspect; 2007 Apr; 115(4):599-605. PubMed ID: 17450230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.